杭州禹泓医药科技有限公司 Reviews, Salaries and Jobs

Company Overview

Nature: 民营公司 Size: 少于50人 Founded: 4年
Industry: 制药/生物工程
Full name: 杭州禹泓医药科技有限公司。

Development Stage

Stage: 战略投资, 8000万人民币。
Ranking: Ranked #24 in Hangzhou医药新药公司 by popularity Ranked #39 in Hangzhou新药研发公司 by popularity Ranked #39 in Hangzhou医药研发公司 by popularity Ranked #106 in Hangzhou药物研发公司 by popularity
Honors: 市级创新型中小企业科技型中小企业 According to algorithm
Salary: 53.9% of positions earn 10-20K, In 2026 vs last yeargrew by 84%.。Master's salary: ¥25.3K.
Recruiting: In 2026 vs 2025decreased by 27%. Demand for highly educated talent: Master's: 6.
Requirement: Education: 硕士 leads with 76.9%. Experience: 不限 leads with 53.8%.
Region: Distributed across 1 regions, 杭州: 100%.

About the Company

杭州禹泓医药科技有限公司成立于2022年10月，位于浙江省杭州市钱塘区医药港小镇。公司以临床需求为中心，以推动药物研发原始创新为己任，新药设计合成、精准评价、快速开发三大创新平台技术，依托创建团队在新药创制领域拥有的丰富经验，形成覆盖同类、全球产品的丰富研发管线，不断向国际化综合性新药研发企业稳步迈进。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

禹泓医药 Financing History (1 rounds)

Manage

战略投资

Capital Market Favor

Latest Financing Round

Date: ?
Amount: 8000万人民币
Investor: 杭州秘银资本，海南慧胜德，...

禹泓医药 How Fast Is Hiring Growing? (8 open positions)

Manage

Growth Rate

2026 vs 2025

2025: Down 17%
2024: Up 20%

禹泓医药 Year-by-Year Hiring:

2023 15 jobs 2024 18 jobs 2025 15 jobs 2026 ? *** 

Hangzhou 8

禹泓医药 Campus Recruitment & Advanced Degree Talent Demand

Master's 6

禹泓医药 Latest Jobs

早研项目管理

杭州 | 硕士以上 | 3-5年 | 全职 | 15000-20000

2026-06-28

Note: How fast is hiring at 杭州禹泓医药科技有限公司 growing? 禹泓医药2025: 15 openings (down 17%), 2024: 18 openings (up 20%), 2023: 15 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

禹泓医药 Master's Degree Job Demand Analysis

(More)

Growth Rate

2026 vs 2025

2025: Down 33%
2024: Up 20%

禹泓医药 Master's Hiring by Year:

2023 10 jobs 2024 12 jobs 2025 8 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Master's Salary 򀀩

How fast is master's hiring at 杭州禹泓医药科技有限公司 growing? 禹泓医药Master's recruitment over the years: 2025: 8 openings (down 33%), 2024: 12 openings (up 20%), 2023: 10 openings.

禹泓医药 — What Are the Salaries Like? (13 records)

Manage

禹泓医药 Salary Overview

￥10-20K

53.9% of roles pay

salary range: 6K - 50K, 53.9% of roles pay ￥10-20K

7.7% 6-8K ***  ? 10-15K ***  ? 15-20K 15.4% 20-30K 23.1% 30-50K

Note: salary statistics are based on 13 salary records from the past year and depend on the job sample. For reference only.

禹泓医药 Salary Ranking

By Category

医疗卫生/美容保健类￥24.4K  生物/制药/化工/环保类  工厂生产类  科研类  计算机/网络/技术类 

How is the salary at 杭州禹泓医药科技有限公司?禹泓医药53.9% of positions earn 10-20K, Undergraduate salary: ¥。医疗卫生/美容保健类 average salary ¥24.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

禹泓医药 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

禹泓医药 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

医疗卫生/美容保健类
61.5% of total 61.5%
生物/制药/化工/环保类
38.5% of total 38.5%
工厂生产类
15.4% of total 15.4%
科研类
15.4% of total 15.4%

Job Location

杭州
100% of total 100%

Education

硕士
76.9% of total 76.9%
本科
15.4% of total 15.4%
大专
7.7% of total 7.7%

Experience

不限
53.8% of total 53.8%
1-3年
23.1% of total 23.1%
3-5年
15.4% of total 15.4%
5-10年
7.7% of total 7.7%

View Detailed Analysis

What does 杭州禹泓医药科技有限公司 require? Who is 禹泓医药 hiring? 禹泓医药 recruitment: 医疗卫生/美容保健类占比最多占61.5%，其次是生物/制药/化工/环保类占38.5%. What education can get in at 禹泓医药? 硕士占比最多占76.9%，其次是本科占15.4%. High education required at 禹泓医药? 硕士占76.9%. Work experience required at 禹泓医药? 不限占比最多占53.8%，其次是1-3年占23.1%. Where are the job locations at 禹泓医药? 杭州占比最多占100%. Based on job postings from the past year, for reference only.